Silo Pharma Inc (SILO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,903 | 4,749 | 3,918 | 4,334 | 3,137 |
| Marketable Securities | 2,130 | 2,110 | 1,949 | 1,926 | 2,315 |
| Other current assets | 242 | 320 | 72 | 0 | 0 |
| TOTAL | $6,804 | $7,388 | $6,164 | $6,373 | $5,604 |
| Non-Current Assets | |||||
| Intangibles | 214 | 217 | 220 | 223 | 238 |
| Other Non-Current Assets | 0 | 0 | 0 | 56 | 58 |
| TOTAL | $214 | $217 | $220 | $280 | $296 |
| Total Assets | $7,018 | $7,605 | $6,385 | $6,653 | $5,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 633 | 578 | 636 | 978 | 1,113 |
| TOTAL | $705 | $650 | $708 | $1,050 | $1,185 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 72 | 72 | 72 | 72 | 72 |
| TOTAL | $632 | $650 | $668 | $686 | $704 |
| Total Liabilities | $1,336 | $1,300 | $1,376 | $1,735 | $1,889 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16,267 | 14,167 | 13,318 | 9,401 | 4,484 |
| Common Shares | 2 | 1 | 1 | 1 | 0 |
| Retained earnings | -21,140 | -19,492 | -18,611 | -17,500 | -16,296 |
| Other shareholders' equity | 9 | 6 | 11 | 10 | 11 |
| TOTAL | $5,682 | $6,305 | $5,009 | $4,917 | $4,011 |
| Total Liabilities And Equity | $7,018 | $7,605 | $6,385 | $6,653 | $5,900 |